EligibleTrials

Clinical trials recruiting for Stage IV Non-small Cell Lung Cancer

7
Recruiting trials
9
US states with sites
4
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 2Not applicable 4

Drugs and treatments being studied

InterventionTrials
Carboplatin1
Cemiplimab1
Cyclophosphamide1
Fludarabine1
Heterogeneously Hypofractionated Radiotherapy1
IOV-40011
Interleukin-2 (IL2)1
Nivolumab1
Paclitaxel1
Tumor Infiltrating Lymphocytes (TIL)1

Where trials are recruiting (top US states)

StateRecruiting trials
Florida2
Ohio2
California1
Kansas1
Kentucky1
Massachusetts1
New York1
Pennsylvania1
Wisconsin1

Top cities

Tampa, Florida 2Boston, Massachusetts 1Cincinnati, Ohio 1Columbus, Ohio 1Los Angeles, California 1Louisville, Kentucky 1Miami, Florida 1Milwaukee, Wisconsin 1New York, New York 1Orlando, Florida 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Stage IV Non-small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.

Lung cancer 2180Stage III Non-small Cell Lung Cancer 6Non-small cell lung cancer 507Unresectable Melanoma 11Thoracic Neoplasms 8Targeted Therapy 8Survivorship 12Respiratory Tract Neoplasms 4Radiotherapy Side Effect 16Palliative Care 5

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Stage IV Non-small Cell Lung Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.